Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
NCT01808937
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: How morphea behaves over time How frequently specific problems occur along with morphea (for example, arthritis) Whether morphea has an autoimmune background
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Scleroderma, Localized
- Morphea
- Frontal Linear Scleroderma en Coup de Sabre
- Scleroderma, Circumscribed
- Scleroderma, Linear
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Up to 90 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Texas Southwestern Medical Center
- Last updated on ClinicalTrials.gov
- May 12, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Texas · 1
- UT Southwestern Medical Center - Department of Dermatology · Dallas, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.